SUMMARY Adenosine and adenine compounds (AMP, cyclic AMP, ADP and ATP) markedly dilated feline and human pial arteries in vitro, the effect being more prominent with increasing tone of the vessel (active tonic contraction induced by prostaglandin F 2r , or serotonin). In contrast, the various adenine compounds were unable to produce any dilatation of extracranial arteries tested (branches of lingual, external maxillary, and superficial temporal arteries). The degree of dilatation depended upon the perivascular potassium concentration, so that low potassium increased E max and reduced ED 60 values. Possible involvement of adenine compounds in the vasodilatory phase of the migraine attack is discussed.
THE VASCULAR REACTION during a migraine attack often comprises an initial constriction followed by a dilatation of large arteries. These circulatory changes have been particularly investigated in the extra-and intracranial circulation.
1 ' 2 Neurological deficits are not uncommon as a result of ischemia during the initial vasoconstrictory phase of the attack. This may cause metabolic changes, i.e. a perivascular increase of H + and K +3 , as well as adenosine 4 has been observed. Similarly, ischemia causes a rapid increase of adenosine and the related adenine compounds AMP and cyclic AMP in cerebral cortical tissue. 5 The content of cyclic AMP in the cerebrospinal fluid, and hence its concentration in the vicinity of pial vessels, is enhanced during a migraine attack. 6 Against this background it is of interest to determine whether adenosine and closely related adenine compounds (AMP, cyclic AMP, ADP and ATP) may cause a sufficiently high degree of vasodilatation in vitro to account for a possible involvement in initiating the vasodilatory phase of a migraine attack.
Methods
Twenty-four adult cats of either sex weighing 2 to 4 kg were used. The animals were killed by exsanguination under barbiturate (Nembutal, 30 mg/kg i.p.) anesthesia, the brain was removed and the middle cerebral arteries, as well as branches of extracranial arteries (lingual and external maxillary), were immediately dissected out. They were kept in aerated Krebs-Ringer (K-R) buffer solution of the following composition (millimolar concentrations): NaCl 118, KC1 4.5, MgSO 4 experiments mock cerebrospinal fluid (CSF buffer) was used instead of K-R buffer solution; it had the following composition (mM): NaCl 120, KC1 3.0, MgCl 2 0.29, NaH 2 PO 4 0.50, Na 2 HPO 4 0.25, NaHCO 3 25, CaCl 2 0.86 and glucose 6.0. Part of the material was immediately used in the experiments, whereas the rest was used after storage in the buffer solution at +4°C for up to 24 hours.
Human vessels from 3 patients were obtained during neurosurgical operations. Segments of pial arteries were removed from normal parts of resected frontal and temporal lobes. In connection with the craniotomy, small branches were taken from the superficial temporal artery of the same patient.
Pieces about 5 mm long from the dissected arteries were mounted between 2 L-shaped metal holders in a manteled organ bath for simultaneous recording of circular isometric tensions as described elsewhere. 7 The tension was measured with force displacement transducers and recorded on a Grass polygraph. The bath contained either the K-R or the CSF buffer solution. It was maintained at 37°C (range 0.5°C) and continuously aerated with a mixture of 95% O 2 and 5% CO 2 , giving a mean pH of 7.38 for the K-R buffer and 7.30 for the CSF buffer. The vessels were given a passive load of 400 dynes and allowed to attain a steady level of tension during a 2 hour accommodation period before testing.
In order to reveal a clear-cut dilatory response the vessels were given an active tonic constriction by either prostaglandin F 2a (PGF 2a ; 2.5 X 10 6 M or 2.5 X 10" Dr. M. Spedding, School of Pharmacy, Sunderland, England), prostaglandin F 2a (Astra), 5-hydroxytryptamine creatinine sulphate (Sigma).
Results
The effect of adenosine, AMP, cyclic AMP, ADP and ATP was first analyzed in the relaxed vessel, i.e. before it was subjected to an active tone. Under these conditions, all adenine compounds caused dilatation of the feline pial artery (table 1), whereas no effect was obtained in extracranial arteries. A more clear-cut dilatation of the preparation was revealed after the vessels had been given an active tone by PGF 2a (see  table) . The PGF 2a -induced contraction remained at a steady level of tension long enough to allow for cumulative application of the drugs to be tested. The amount of dilatation was proportional to the degree of active tone (PGF 2o 2.5 X 10 arteries were principally the same as those obtained in feline arteries.
As shown in figure 2 , an increase in the K + concentration from 4.5 mM to 9.0 mM resulted in a less pronounced dilatory effect of the adenine compounds (adenosine and ATP tested). On the other hand, the sensitivity of the vessels to adenine compounds was enhanced in a bath containing CSF buffer instead of K-R buffer ( fig. 2 ), probably as a result of the change in K + concentration from 4.5 to 3.0 mM. It is our experience that the survival time of the vascular segments is shorter in the CSF buffer than in the K-R buffer; hence the majority of tests were performed in the K-R buffer.
The presence of theophylline and aminophylline (3 X 10 7 -3 X 10 4 M) in the organ bath caused a decreased vascular sensitivity particularly at the lower concentrations of the adenine compounds (adenosine and ATP tested, fig. 3 ). The outcome of the response may, in part, be related to the fact that theophylline and aminophylline, at the high concentrations, slightly reduced the amount of the PGF^ induced active tone of the vessel. 2-2'-pyrridyl-isatogen has been reported to antagonize the response to ATP on smooth muscle preparations. 8 This substance (tested at a concentration from 3 X 10 7 to 3 X 10" no effect on the ATP-induced vascular dilatation in these concentrations.
Discussion
This study has shown that all adenine compounds tested cause a marked vasodilatation of feline and human pial -but not extracranial -arteries in vitro. Similarly, intracarotid infusion of ATP induces a marked increase in cerebral blood flow in the baboon, 9 as does adenosine in the dog. 10 Topical application of adenosine on pial arteries induces vasodilatation in the cat. 11 The amount of dilatation is more marked when the tone is increased before testing. 12 But even a markedly relaxed vessel (with a tangential tension in the wall estimated to be only about l A of the normal tension in vivo 13 ), dilates upon exposure to the adenine compounds. The dilatory capacity is not restricted to the large pial vessels presently tested but is, in relative terms, equally prominent in vessels with diameters ranging from about 50 to 300 n.
n The vessels dilate to a similar degree irrespective of whether the foregoing constriction has been induced by 5-HT or PGF 2Q . This arrangement may mimic the events taking place during the vasoconstrictory phase of a migraine attack, in which a transient increase of circulating 5-HT and
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prostaglandin is believed to occur.
14 -
15
The dilatory capacity is dependent on the potassium concentration; an increase in K + diminishes the dilatation. 16 At a K + concentration of 3.0 mM (CSF buffer) the vessels became more sensitive upon exposure to adenyl compounds. The influence of a further decrease in K + on adenyl-mediated dilatations was not investigated, since only small diminutions of K + occur during physiological and pathophysiological conditions.
17 '
18
The influence of H + concentration on the vascular dilatory effect of adenosine has been investigated in pial arteries at local perivascular application. 16 The effect of adenosine in an alkaline surrounding was not altered, but it was decreased in an acidic milieu. In the coronary circulation, however, the dilatory effect of adenosine was enhanced during systemic acidosis and diminished during alkalosis. 19 The order of potency of adenine compounds in causing relaxation has been evaulated in coronary vessels. Most workers find ATP and ADP to be the most potent agents on the coronary vasculature; AMP, adenosine and cyclic AMP are one-fourth to one-third less potent than ATP. 20 This is principally in agreement with the findings obtained in this study.
It is notable that ATP administered systemically has effects beyond the blood-brain barrier: the observed increase in cerebral blood flow is accompanied by an increase in CMRO 2 .
9 In this context it should be recalled that ADP may be released from platelets during the early phase of a migraine attack in conjunction with an increased platelet aggregability. 21 '
22
Administration of the phosphodiesterase inhibitor, aminophylline, has been suggested as a possible way to treat cerebral vasospasm. 23 The vasodilatory effect resulting from the increase in adenine compounds may, however, be partly counteracted by the presently observed inhibitory effect of aminophylline on the adenine-mediated dilatations. 11 ' 24 There is at present no convincing evidence for an interaction of adenine compounds with specific adenine receptors. A neuronal localization of ATP in purinergic nerves has been suggested by Burnstock. 20 It is possible that adenine compounds exert their vasodilatory effect by a direct action on the smooth muscle cells in the vessel wall. 26 Whatever this mechanism is, a marked difference exists between the intra-and extracranial carotid vasculature, in the sense that no clearcut dilatation was obtained in the extracranial arteries under the present in vitro conditions. Further, the action is apparently dependent upon the perivascular concentrations of K + and H + and on the present state of vascular tone. It is generally accepted that both intracranial and extracranial vessels dilate following the constrictor phase of a migraine attack. 1 2 However, little is known about the cause of vasodilatation in migraine and it may be different in these 2 vascular territories. A fall in circulating levels of vasoconstrictor agents such as 5-HT u and noradrenaline 26 has been demonstrated, and a local release of prostacyclin, causing vasodilatation, has been suggested. 27 Ischemia during the vasoconstrictory phase will cause an increase of adenine compounds in the brain. It is generally considered that dilatation of extracranial vessels is one causative factor for the headache phase. The present results would indicate that adenine compounds do not contribute to the vasodilatation in this vascular territory. However, dilatation of intracranial vessels may cause headache.
because diffusional equilibrium between brain and blood is established almost instantaneously. 6 -8 Since use of a gas tracer presents technical difficulties, attempts have been made to employ nongaseous tracers to measure LCBF. u C-antipyrine has been used with some success, but it provides LCBF's which are less than those obtained using inert gases. Transfer of 14 C-antipyrine from blood to brain is limited by the comparatively low diffusion coefficient of that tracer in the brain. The cerebrovascular PS value (permeability X surface area) of u C-antipyrine is about 0.020 cm 3 sec 1 g 1 , and is not sufficiently high to satisfy the assumptions of the Kety method. 4 '
